EdgeWater 10/19/2010 10:48:00 PM
News / Finance

Drug Stocks in Focus (LLY, AGN, MRK, BMY)

Drug Stocks in Focus

Shares of Eli Lilly & Co. (NYSE:LLY) went down 1.63% to $37.44. The company announced that the Board has declared a dividend for the fourth quarter of 2010 of $0.49 a share on outstanding common stock. This is the same dividend as was paid in the first three quarters of 2010 and brings the total annual dividend for 2010 to $1.96 per share.

The average daily volume of the stock is 5.19 million shares.

Allergan, Inc. (NYSE:AGN) fell 1.38% to $71.61. Citigroup Inc. raised its target price from $66 to $82 for Allergan Inc. on Monday. Yesterday, the company said that the Food and Drug Administration given the green signal for the company’s Botox – for the treatment of chronic migraines.

Over the past 52-week, the stock had traded within the range of $53.32-$72.98. At current market price, the market capitalization of the company stood at $21.73 billion.

Merck & Co., Inc. (NYSE:MRK) slid 0.89% and currently trading at $36.90. Merck & Co., Inc. is a global health care company that delivers health solutions through its medicines, vaccines, biologic therapies, and consumer and animal products, which it markets directly and through its joint ventures.

Bristol Myers Squibb Co. (NYSE:BMY) dropped 1.57% to $26.90. Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis.

Over the past 52-week, the stock had traded within the range of $21.67-$28 and is up more than 5% year-to-date.

Article published by Wall Street Grand. Visit the Wall Street Grand Club today.

SAFE LINK

Disclaimer:

For our full disclosure please visit - http://www.wallstreetgrand.com/disclosure.html